SESSION TITLE: Asthma Posters II
SESSION TYPE: Original Investigation Poster
PRESENTED ON: Wednesday, October 29, 2014 at 01:30 PM - 02:30 PM
PURPOSE: To evaluate the influence of patient characteristics and mood disorders on asthma control.
METHODS: This is a pilot Cross sectional study on 100 patients with asthma attending asthma clinic and the ER of a tertiary hospital in Central Kerala. We collected data of age, sex, BMI, smoking history, socioeconomic status, pulmonary function, asthma control using ACT, history of anxiety or depression using Hospital Anxiety and Depression test. The data obtained was analyzed using Epi Info Software and Chi Square test (or Fisher’s exact test for variables with less than 5 frequencies per category) was used to find the significance of the correlations.
RESULTS: From our study it was found that poor asthma control was commonly seen in older age groups (51-65 yrs(100%) and >65 yrs (100%), p=0.0288), Women (89.4% women vs 73.5% men p= 0.0262), people with higher BMI (25-29.9(96.3%), >30(100%), p=0.0175) and people with mood disorders(94.6% vs 70.5%, p=0.0067). PFT was available for only for 79 patients, as the rest of the patients had come to the ER for acute exacerbation of bronchial asthma and hence were unable to perform the PFT. Of the 79 patients we found that poor pulmonary function was associated with poor asthma control. (FEV1<80%(16.45%), FEV1<70%, 22.85%, FEV1<60%, 35.45). We could find no correlation between socio economic status and control of asthma (p=0.0571).
CONCLUSIONS: There is positive correlation between mood disorders, older age, female sex, higher BMI and asthma control. We propose that correlation between mood disorders and asthma control could be bidirectional, which calls for further studies in this subject.
CLINICAL IMPLICATIONS: Assessing the presence or absence of moon disorders and appropriately treating the condition is important. Underlying anxiety and depression if not considered may lead to poor adherence, higher rate of exacerbation, higher medical costs, unnecessary medication changes and testing and potentially higher mortality.
DISCLOSURE: The following authors have nothing to disclose: Veena Iyer, Babilu Co, Sobha Subramaniam
No Product/Research Disclosure Information